Spire ‘cautiously optimistic’ as FY20 results exceed analysts’ expectations

Spire Healthcare said today that it is ‘cautiously optimistic’ trading will return to pre-pandemic levels in 2021 as it reported FY20 results ahead of consensus. Revenue fell by 6.2% to £919.9m for the year ended 31 December 2020, but remained ahead of the £850m forecast by analysts. Despite a 20% fall in revenue in the…

You must be a HM Subscriber to view this content.

Subscribe Now »